Literature DB >> 18090666

Role of fat mass and adipokines in chronic kidney disease.

Jonas Axelsson1, Peter Stenvinkel.   

Abstract

PURPOSE OF REVIEW: As traditional risk factors cannot alone explain the high prevalence and incidence of cardiovascular disease in chronic kidney disease, the complex of insulin resistance, oxidative stress, and endothelial dysfunction has increasingly been studied as an important non-traditional risk factor. Recent studies show that the adipose tissue is a complex organ with pleiotropic functions far beyond the mere storage of energy. Fat tissue secretes a number of adipokines including leptin and adiponectin, as well as cytokines, such as resistin, visfatin, tumor-necrosis factor-alpha and interleukin-6. RECENT
FINDINGS: Adipokine serum levels are markedly elevated in chronic kidney disease, likely due to a decreased renal excretion. Evidence suggests that these pluripotent signaling molecules may have multiple effects modulating insulin signaling, endothelial health and vascular outcome.
SUMMARY: Fat tissue is a storage depot for energy and a source of circulating signaling molecules. It plays an important role in the catabolic uremic milieu, and has been linked to systemic inflammation and uremic anorexia. Further research is needed to investigate the complex interactions between adipokine signaling networks and its effects on vascular health and outcome in chronic kidney disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18090666     DOI: 10.1097/MNH.0b013e3282f2905f

Source DB:  PubMed          Journal:  Curr Opin Nephrol Hypertens        ISSN: 1062-4821            Impact factor:   2.894


  9 in total

1.  Enhancement of renal epithelial cell functions through microfluidic-based coculture with adipose-derived stem cells.

Authors:  Hui-Chun Huang; Ya-Ju Chang; Wan-Chun Chen; Hans I-Chen Harn; Ming-Jer Tang; Chia-Ching Wu
Journal:  Tissue Eng Part A       Date:  2013-07-05       Impact factor: 3.845

2.  Ketoacid Supplementation Partially Improves Metabolic Parameters in Patients on Peritoneal Dialysis.

Authors:  Jie Dong; Yan-Jun Li; Rong Xu; Talat Alp Ikizler; Hai-Yan Wang
Journal:  Perit Dial Int       Date:  2015-09-15       Impact factor: 1.756

3.  The association between plasma visfatin levels and ED.

Authors:  Ö F Karataş; M E Yıldırım; H T Celik; H Badem; M Çaviş; E Çimentepe
Journal:  Int J Impot Res       Date:  2015-02-19       Impact factor: 2.896

4.  Correlates of insulin resistance in older individuals with and without kidney disease.

Authors:  Michael Landau; Manjula Kurella-Tamura; Michael G Shlipak; Alka Kanaya; Elsa Strotmeyer; Annemarie Koster; Suzanne Satterfield; Eleanor M Simsonick; Bret Goodpaster; Anne B Newman; Linda F Fried
Journal:  Nephrol Dial Transplant       Date:  2011-01-19       Impact factor: 5.992

5.  Elevated plasma tumor necrosis factor-α receptor 2 and resistin are associated with increased incidence of kidney function decline in Chinese adults.

Authors:  Gang Liu; Yueyi Deng; Liang Sun; Xingwang Ye; Pang Yao; Yao Hu; Feijie Wang; Yiwei Ma; Huaixing Li; Yong Liu; Qi Sun; Xu Lin
Journal:  Endocrine       Date:  2015-11-21       Impact factor: 3.633

6.  Increased crystal-cell interaction in vitro under co-culture of renal tubular cells and adipocytes by in vitro co-culture paracrine systems simulating metabolic syndrome.

Authors:  Jun Ichikawa; Atsushi Okada; Kazumi Taguchi; Yasuhiro Fujii; Li Zuo; Kazuhiro Niimi; Shuzo Hamamoto; Yasue Kubota; Yukihiro Umemoto; Yasunori Itoh; Takahiro Yasui; Noriyasu Kawai; Keiichi Tozawa; Kenjiro Kohri
Journal:  Urolithiasis       Date:  2013-10-27       Impact factor: 3.436

Review 7.  Weight loss interventions in chronic kidney disease: a systematic review and meta-analysis.

Authors:  Sankar D Navaneethan; Hans Yehnert; Fady Moustarah; Martin J Schreiber; Philip R Schauer; Srinivasan Beddhu
Journal:  Clin J Am Soc Nephrol       Date:  2009-09-17       Impact factor: 8.237

8.  Is there a relationship between serum vaspin levels and insulin resistance in chronic renal failure?

Authors:  Can Demir; Akif Dogantekin; Ali Gurel; Suleyman Aydin; Huseyin Celiker
Journal:  Pak J Med Sci       Date:  2019 Jan-Feb       Impact factor: 1.088

9.  Systemic fate of the adipocyte-derived factor adiponectin.

Authors:  Nils Halberg; Todd D Schraw; Zhao V Wang; Ja-Young Kim; James Yi; Mark P Hamilton; Kate Luby-Phelps; Philipp E Scherer
Journal:  Diabetes       Date:  2009-07-06       Impact factor: 9.461

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.